Boothbay Fund Management, LLC Iveric Bio, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
BUY
$18.67 - $24.56 $10.7 Million - $14.1 Million
572,200 Added 819.77%
642,000 $15.6 Million
Q4 2022

Feb 14, 2023
SELL
$17.24 - $23.95 $41,375 - $57,480
-2,400 Reduced 3.32%
69,800 $1.49 Million
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $385,400 - $762,190
41,000 Added 131.41%
72,200 $1.3 Million
Q2 2022

Aug 15, 2022
BUY
$9.12 - $18.9 $284,544 - $589,680
31,200 New
31,200 $300,000
Q4 2021

Feb 14, 2022
SELL
$13.83 - $18.78 $275,217 - $373,722
-19,900 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.07 - $17.5 $140,693 - $348,250
19,900 New
19,900 $323,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email